Skip to main content
. Author manuscript; available in PMC: 2013 Jun 6.
Published in final edited form as: Head Neck. 2012 Feb 6;34(9):1269–1276. doi: 10.1002/hed.21917

TABLE 1.

Effects of half-maximal effective concentrations (EC50) of vandetanib on the invasion of HNSCC cell lines.

HNSCC cell line Vandetanib EC50, nM
PCI-15B 558
PCI-37A 1695
UM-22A 0.3
SCC-25 10
UM-22B 2424
PCI-37B 1726

Abbreviation: HNSCC, head and neck squamous cell carcinoma.